UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▼ | Disease Ontology |
---|---|---|---|---|---|
A0A834DRW8 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A7E6DDD0 | Peptidyl-glycine alpha-amidating monooxygenase isoform X10 |
|
1 | 0 |
|
A0A6J2MY87 | Pannexin |
|
2 | 0 |
|
A0A7E6DB04 | Peptidyl-glycine alpha-amidating monooxygenase isoform X4 |
|
1 | 0 |
|
A0A6J2MN15 | Paraoxonase |
|
2 | 0 |
|
A0A7E6DC31 | Peptidyl-glycine alpha-amidating monooxygenase isoform X6 |
|
1 | 0 |
|
A0A6J2LQK7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A834DLP1 | Pannexin |
|
2 | 0 |
|
A0A834DTR7 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A6J2LCI4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6J2L5Q7 | A disintegrin and metalloproteinase with thrombospondin motifs 5 |
|
2 | 0 |
|
A0A6J2LVV0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7E6DAX3 | Peptidyl-glycine alpha-amidating monooxygenase isoform X8 |
|
1 | 0 |
|
A0A6J2LSV8 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A6J2L1W8 | Beta-secretase 2 |
|
2 | 0 |
|
A0A834ACU7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6J2M950 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A7E6DX34 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7E6ECN4 | P2X purinoceptor |
|
1 | 0 |
|
A0A833YBZ7 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A834DVU0 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A7E6E5C2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A833ZJK3 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A833ZH84 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A834AAD2 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024